CCL24 and pulmonary fibrosis: Similarly, blocking CCL24 using a monoclonal antibody reduced collagen content and white blood cell counts in BAL fluid in the bleomycin-induced pulmonary fibrosis model [121], reinforcing a role for the CCL24-CCR3 axis in dermal and pulmonary inflammation, fibrosis, and vasculopathy.